drugset / Trial / NCT01287793
Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects
RandomizedCrossoverDouble-blind
Summary
Administration of a single 50 mg or 200 mg dose of tigecycline will not cause a change in QT/QTc intervals.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | Tigecycline | Small molecule | 50 mg | Intravenous |
| Subject | Tigecycline | Small molecule | 200 mg | Intravenous |
Indications
No indication recorded.